Discussion
The title compound is ab iologically active derivative of curcumin. During the last two decades, numerous studies have shown that curcumin has avariety of biological and pharmacological activities such as anti-carcinogen, immuno-modulation, anti-oxidant, anti-angiogenesis, anti-inflammation and chemoprevention [2] [3] [4] [5] . However, pre-clinical and clinical studies have found that the potential beneficial effects of curcumin on various disease preventions and treatments are limited by its poor pharmacokinetic properties [6, 7] . It is suggested that the presence of the methylene group and b-diketone moiety contributes to the instability of curcumin under physiological conditions [8, 9] . In our previous study, as eries of mono-carbonyl analogues of curcumin were designed by deleting the reactive b-diketone moiety and synthesized [10] [11] [12] [13] . Part of bisbenzylidene cyclopentanone derivatives showed stronger bio-activities than curcumin. As part of our research in this area, the title compound was synthesized. 
